You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recurrent Non Metastatic Prostate Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Beverly Hills, Los Angeles, Pasadena

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +5 more
  • phenelzine sulfate
  • +2 more
  • Beverly Hills, California
  • +3 more
Aug 19, 2022

Prostate Cancer Trial in Madison (pTVG-HP, Nivolumab, GM-CSF)

Active, not recruiting
  • Prostate Cancer
  • pTVG-HP
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Feb 7, 2022

Prostate Cancer Trial in United States (Olaparib, Durvalumab)

Active, not recruiting
  • Prostate Cancer
  • Duarte, California
  • +7 more
Mar 30, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Metastatic Castration-resistant Prostate Cancer, Recurrent Epithelial Ovarian Cancer, Breast Cancer Trial (AsiDNA, Olaparib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • (no location specified)
Jan 17, 2023

Prostate Cancer Metastatic Trial in New York (Actinium-J591, Stereotactic Body Radiation Therapy, Androgen Deprivation Therapy)

Not yet recruiting
  • Prostate Cancer Metastatic
  • New York, New York
    Weill Cornell Medicine - New York Presbyterian Hospital
Oct 3, 2022

Prostate Tumors, Prostatic Cancer, Prostate Cancer Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, 18F-FDG,

Enrolling by invitation
  • Prostate Neoplasms
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Belgium (Darolutamide, metastasis-directed

Recruiting
  • Prostate Cancer
  • +4 more
  • Aalst, Belgium
  • +6 more
Jan 25, 2023

Metastatic Castration Sensitive Prostate Cancer Trial in New York (Degarelix, Ipilimumab, Radical Prostatectomy)

Active, not recruiting
  • Metastatic Castration Sensitive Prostate Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 4, 2022

Recurrent Prostate Cancer After Surgery Trial in Rochester (Daily-adaptive Stereotactic Body Radiation Therapy)

Not yet recruiting
  • Recurrent Prostate Cancer After Surgery
  • Daily-adaptive Stereotactic Body Radiation Therapy
  • Rochester, New York
    Wilmot Cancer Institute - Dept of Radiation Oncology
Jul 7, 2023

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated
  • Glioma
  • +23 more
  • Tucson, Arizona
  • +11 more
Sep 30, 2022

Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

Not yet recruiting
  • Prostate Cancer
  • Biochemically Recurrent
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial

Active, not recruiting
Has Results
  • Hormone-Resistant Prostate Cancer
  • +6 more
  • Pembrolizumab
  • pTVG-HP Plasmid DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 8, 2022

Darolutamide, Enzalutamide and Apalutamide and How Well These

Not yet recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Whippany, New Jersey
    Bayer
Aug 25, 2023

Circulating Tumor Cells in High Risk and Early Metastatic

Recruiting
  • High Risk Prostate Carcinoma
  • +3 more
  • Blood collection
  • Bala-Cynwyd, Pennsylvania
  • +1 more
Jun 28, 2022

High Risk Prostate Carcinoma Trial in Gyeonggi-do, Seoul, Soeul ([F-18]Florastamin)

Recruiting
  • High Risk Prostate Carcinoma
  • Gyeonggi-do, Korea, Republic of
  • +5 more
Jun 29, 2023

Prostate Cancer Trial run by the National Cancer Institute (NCI) (PROSTVAC-V, PROSTVAC-F, MSB0011359C (M7824))

Recruiting
  • Prostate Cancer
  • PROSTVAC-V
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

NSCLC Trial in Seoul (Lazertinib/Pemetrexed/Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 23, 2023

Recurrent Prostate Cancer Patients

Not yet recruiting
  • Recurrent Prostate Cancer
    • San Francisco, California
      Power Life Sciences
    Sep 30, 2023

    Urothelial Cancer, Bladder Cancer, Genitourinary Cancer Trial run by the NCI (M7824, M9241, Stereotactic body radiation therapy

    Recruiting
    • Urothelial Cancer
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues

    Active, not recruiting
    Has Results
    • Castration-Resistant Prostate Carcinoma
    • +6 more
    • San Francisco, California
    • +1 more
    Sep 20, 2022

    Prostate Cancer, Recurrent Prostate Cancer Trial in Tampa (F-DCFPyL Injection, PSMA PET)

    Recruiting
    • Prostate Cancer
    • Recurrent Prostate Cancer
    • F-DCFPyL Injection
    • PSMA PET
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 24, 2023

    NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +32 more
    • (no location specified)
    Mar 30, 2023

    Called DEAR, to Learn More About Treatment With Darolutamide,

    Active, not recruiting
    • Non-metastatic Castration-resistant Prostate Cancer
    • Darolutamide (Nubeqa, BAY1841788)
    • +2 more
    • Whippany, New Jersey
      Bayer
    Jan 13, 2023

    Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester

    Active, not recruiting
    • Metastatic Prostate Adenocarcinoma
    • +6 more
    • Intensity-Modulated Radiation Therapy
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 5, 2023